Please wait a minute...
Journal of Neurorestoratology  2017, Vol. 5 Issue (1): 1-4    doi: 10.2147/JN.S120524
Case Report     
Olfactory ensheathing cell transplantation for a patient with chronic sciatic nerve injury
Feng Zhang1,2, Xiangzhi Meng2, Fang Lu2, Aixian Liu2, Hongyun Huang1,2
1 Cell Therapy Center, Beijing Hongtianji Neuroscience Academy;
2 Neurorehabilitation Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, People’s Republic of China
Download: PDF (132 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: To observe the result of olfactory ensheathing cell (OEC) transplantation in a patient with chronic sciatic nerve injury. Case report: A 53-year-old male patient with chronic (1 year) sciatic nerve injury on left side received OEC transplantation at the lesion site. He received follow-up assessment according to the American Spinal Injury Association standard at 10 days, 6 months, and 1 year after OEC therapy. The muscle strength of his left lower limb increased and numbness decreased during the early stage of cell therapy. His motor function improved with each evaluation. His limp walking gait recovered, and numbness sensation got nearly normal after 1 year of follow-up. There were no side effects. Conclusion: OEC transplantation may be an option for chronic peripheral (sciatic) nerve injury.

Key wordsolfactory ensheathing cell transplantation      sciatic nerve injury      peripheral nerve injury      function improvement      neurorestoration     
Received: 24 August 2016      Published: 26 December 2017
Corresponding Authors: Hongyun Huang, Cell Therapy Center, Beijing Hongtianji Neuroscience Academy, No. 1 Gucheng Street, Shijingshan District, Beijing, People’s Republic of China Tel +86 139 1011 6608 Email hongyunh@gmail.com   
Cite this article:

Feng Zhang, Xiangzhi Meng, Fang Lu, Aixian Liu, Hongyun Huang. Olfactory ensheathing cell transplantation for a patient with chronic sciatic nerve injury. Journal of Neurorestoratology, 2017, 5: 1-4.

URL:

http://jnr.tsinghuajournals.com/10.2147/JN.S120524     OR     http://jnr.tsinghuajournals.com/Y2017/V5/I1/1

1. Radtke C, Kocsis J.Peripheral nerve injuries and transplantation of olfactory ensheathing cells for axonal regeneration and remyelination: fact or fiction?Int J Mol Sci. 2012;13:12911-12924.
2. Deumens R, Koopmans G, Lemmens M, et al.Neurite outgrowth promoting effects of enriched and mixed OEC/ONF cultures.Neurosci Lett. 2006;397(1-2):20-24.
3. Au E, Richter M, Vincent A, et al.SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair.J Neurosci. 2007;29:7208-7236.
4. Cao L, Zhu Y, Su Z, et al.Olfactory ensheathing cells promote migration of Schwann cells by secreted nerve growth factor.Glia. 2007;55:897-904.
5. Verdú E, Navarro X, Gudi?o-Cabrera G, et al.Olfactory bulb ensheathing cells enhance peripheral nerve regeneration.Neuroreport. 1999;10:1097-1101.
6. Dombrowski M, Sasaki M, Lankford K, Kocsis J, Radtke C.Myelination and nodal formation of regenerated peripheral nerve fibers following transplantation of acutely prepared olfactory ensheathing cells.Brain Res. 2006;1127:1-8.
7. Cheng S, Ruan H, Wu X. [Olfactory ensheathing cells enhance functional recovery of injured sciatic nerve].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi.2003;17:18-36. Chinese.
8. Delaviz H, Joghataie M, Mehdizadeh M, Bakhtiyari M, Nobakht M, Khoei S.Transplantation of olfactory mucosa improve functional recovery and axonal regeneration following sciatic nerve repair in rats.Iran Biomed J. 2008;12:197-202.
9. Radtke C, Aizer A, Agulian S, Lankford K, Vogt P, Kocsis J.Transplantation of olfactory ensheathing cells enhances peripheral nerve regeneration after microsurgical nerve repair.Brain Res. 2009;1274:10-17.
10. People’s Republic of China, Ministry of Public Health, Science and Technology Bureau, 1991. Instruction for prepare and clinical application of the aborted human fetuses (91-006).
11. Chen L, Xi H, Huang H, et al.Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke.Cell Transplant. 2013;22(Suppl 1):S83-S91.
12. Xi H, Chen L, Huang H, et al.Preliminary report of multiple cell therapy for patients with multiple system atrophy.Cell Transplant. 2013;22(Suppl 1):S93-S99.
13. Huang H, Raisman G, Sanberg PR, Sharma H, Chen L.Neurorestoratology, V4. New York: Nova Biomedical; 2015:313-357.
14. Jin W-H, Wei Z-R, Sun G-F, Tang X-J, Wang D-L.Autologous peripheral blood stem cell transplantation for treatment of peripheral nerve injury. Available from: http://www.crter.org/CN/abstract/abstract176.shtml. Accessed August 24, 2016.
15. Rodrigues MC, Rodrigues AA, Glover LE Jr, Voltarelli J, Borlongan CV.Peripheral nerve repair with cultured Schwann cells: getting closer to the clinics.Sci World J. 2012;(5):413091.
16. Millesi H.Factors affecting the outcome of peripheral nerve surgery.Microsurgery. 2006;26(4):295-302.
17. Huang H, Chen L, Sanberg P.Cell therapy from bench to bedside translation in CNS neurorestoratology era.Cell Med. 2010;1(1):15-46.
18. Huang H, Raisman G, Sanberg PR, Sharma H, Chen L.Neurorestoratology, V1. New York: Nova Biomedical; 2015:67-91.
19. Huang HY, Chen L, Wang HM, et al.Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury.Chin Med J. 2003;116(10):1488-1491.
20. Huang H, Chen L, Xi H, et al.Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.Clinical Transplant. 2008;22:710-718.
21. Chen L, Huang H, Xi H, et al.Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial.Cell Transplant. 2010;19(2):185-191.
22. Huang H, Chen L, Xi H, et al. [Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi.2009;23(1):14-20. Chinese.
23. Chen L, Huang H, Xi H, et al.A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries.Cell Transplant. 2014;23(Suppl 1):S35-S44.
24. Chen L, Chen D, Xi H, et al.Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations.Cell Transplant. 2012;21(Suppl 1):S65-S77.
25. Huang H, Xi H, Chen L, Zhang F, Liu Y.Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.Cell Transplant. 2012;21(Suppl 1):S23-S31.
26. Guérout N, Duclos C, Drouot L, et al.Transplantation of olfactory ensheathing cells promotes axonal regeneration and functional recovery of peripheral nerve lesion in rats.Muscle Nerve. 2011;43(4):543-551.
27. You H, Wei L, Liu Y, et al.Olfactory ensheathing cells enhance Schwann cell-mediated anatomical and functional repair after sciatic nerve injury in adult rats.Exp Neurol. 2011;229(1):158-167.
28. Huang H, Wang H, Chen L, et al. [Influence factors for functional improvement after Olfactory ensheathing cell transplantation for chronic spinal cord injury].Zhongguo Xiufu Chongjian Waike Zazhi. 2006;20(4):434-438.
29. Steinberg GK, Kondziolka D, Wechsler LR, et al.Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a Phase 1/2a study.Stroke. 2016;47(7):1817-1824.
[1] Xiaoling Guo, Qun Xue, Jianhua Zhao, Yi Yang, Yang Yu, Dezhong Liu, Jing Liu, Wenwu Yang, Linsen Mu, Ping Zhang, Tianyi Wang, Hongyan Han, Shoufeng Liu, Yuhua Zhu, Tao Wang, Chuanqiang Qu, Chuanqiang Qu. Clinical diagnostic and therapeutic guidelines of stroke neurorestoration (2020 China version)[J]. Journal of Neurorestoratology, 2020, 8(4): 241-251.
[2] Hongyun Huang, Wenyong Gao, Zhenghui Yan, Aibing Liu, Xijing He, Ming Lu, Ying Liu, Yixin Shen, Jianhua Zhao, Zuncheng Zheng, Tiansheng Sun, Yaojian Rao, Yaojian Rao. Standards of clinical-grade olfactory ensheathing cell culture and quality control (2020 China Version)[J]. Journal of Neurorestoratology, 2020, 8(4): 217-231.
[3] Hongyun Huang, Lin Chen, Gengsheng Mao, Hari Shanker Sharma. Clinical neurorestorative cell therapies: Developmental process, current state and future prospective[J]. Journal of Neurorestoratology, 2020, 8(2): 61-82.
[4] Zuhal Altunkaynak Berrin, Delibaş Burcu, Altun Gamze, Gülsüm Deniz Ömür. Melatonin and sciatic nerve injury repair: a current perspective[J]. Journal of Neurorestoratology, 2018, 6(1): 49-60.
[5] Zhongju Shi, Zhijian Wei, Shiqing Feng, Gustavo Moviglia, Lin Chen, Ping Wu. Highlights for the 10th Annual Conference of the International Association of Neurorestoratology[J]. Journal of Neurorestoratology, 2018, 6(1): 84-87.
[6] Lin Chen, Yuqi Zhang, Xijing He, Saberi Hooshang. Comparison of intramedullary transplantation of olfactory ensheathing cell for patients with chronic complete spinal cord injury worldwide[J]. Journal of Neurorestoratology, 2018, 6(1): 146-151.
[7] Hongyun Huang, Lin Chen, Qingyan Zou, Fabin Han, Tiansheng Sun, Gengsheng Mao, Xijing He. Clinical cell therapy guidelines for neurorestoration (China version 2016)[J]. Journal of Neurorestoratology, 2017, 5(1): 39-46.
[8] Qiang Ao. Progress of nerve bridges in the treatment of peripheral nerve disruptions[J]. Journal of Neurorestoratology, 2016, 4(1): 107-113.
[9] Hongyun Huang, Lin Chen. Neurorestorative process, law, and mechanisms[J]. Journal of Neurorestoratology, 2015, 3(1): 23-30.
[10] Hongyun Huang, Lin Chen, Paul R Sanberg. Developmental history of neurorestoratology[J]. Journal of Neurorestoratology, 2015, 3(1): 31-38.